Product Type: | Mouse monoclonal IgG2b, primary antibodies |
---|---|
Species reactivity: | Human, Mouse |
Applications: | WB, IF-Cell, IHC-P, FC |
Clonality: | Monoclonal |
Clone number: | 8-E5 |
Form: | Liquid |
Storage condition: | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
Storage buffer: | 1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide. |
Concentration: | 2ug/ul |
Purification: | Protein A affinity purified. |
Molecular weight: | Predicted band size: 33 kDa |
Isotype: | IgG2b |
Immunogen: | Synthetic peptide within human CD80 aa 74-118 / 288. |
Positive control: | Human brain tissue lysates, human brain tissue, SH-SY5Y, Hela. |
Subcellular location: | Membrane. |
Recommended Dilutions:
WB IF-Cell IHC-P |
1:1,000 1:100-1:200 1:50 |
Uniprot #: | SwissProt: P33681 Human | Q00609 Mouse |
Alternative names: | Activation B7-1 antigen B lymphocyte activation antigen B7 B7 B7-1 B7-1 antigen B7.1 BB1 CD28 antigen ligand 1 CD28LG CD28LG1 CD80 CD80 antigen (CD28 antigen ligand 1, B7-1 antigen) CD80 antigen CD80 molecule CD80_HUMAN Costimulatory factor CD80 costimulatory molecule variant IgV-CD80 CTLA-4 counter-receptor B7.1 LAB7 T-lymphocyte activation antigen CD80 |
Fig1:
Western blot analysis of CD80/B7-1 on human brain tissue lysates with Mouse anti-CD80/B7-1 antibody (M1007-10) at 1/1,000 dilution. Lysates/proteins at 40 µg/Lane. Predicted band size: 33 kDa Observed band size: 60 kDa Exposure time: 3 minutes 10 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (M1007-10) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. |
|
Fig2: Immunohistochemical analysis of paraffin- embedded human brain tissue using using anti-CD80 Mouse mAb (Cat. # M1007-10). | |
Fig3:
Immunocytochemistry analysis of SH-SY5Y cells labeling CD80/B7-1 with Mouse anti-CD80/B7-1 antibody (M1007-10) at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 30 minutes, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes, and then blocked with 2% BSA for 30 minutes at room temperature. Cells were then incubated with Mouse anti-CD80/B7-1 antibody (M1007-10) at 1/100 dilution in 2% BSA overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. |
Fig4:
Immunocytochemistry analysis of Hela cells labeling CD80/B7-1 with Mouse anti-CD80/B7-1 antibody (M1007-10) at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 30 minutes, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes, and then blocked with 2% BSA for 30 minutes at room temperature. Cells were then incubated with Mouse anti-CD80/B7-1 antibody (M1007-10) at 1/100 dilution in 2% BSA overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. |